Concepedia

Richard Sparks

RS

Statistics

Publications

42

Citations

4.7K

H-Index

30

Active since

1995

Affiliations

Incyte (United States)(Current)

Experimental Station

Mayo Clinic

Vanderbilt University

Oak Ridge Associated Universities

Richard Sparks is an author at Incyte (United States) specializing in medicine, radiology, and nuclear medicine.

Top concepts

Publications per year

1995–2025

42

Publications

42

OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine.

Michael G. Stabin, Richard Sparks, Eric A. Crowe · PubMed · 2005 · 1.4K citations

Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity

Xiangdong Liu, Niu Shin, Holly K. Koblish et al. · Blood · 2010 · 552 citations · Full text

INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology

Eddy W. Yue, Richard Sparks, Padmaja Polam et al. · ACS Medicinal Chemistry Letters · 2017 · 290 citations · Full text

Hydroxyamidine Inhibitors of Indoleamine-2,3-dioxygenase Potently Suppress Systemic Tryptophan Catabolism and the Growth of IDO-Expressing Tumors

Holly K. Koblish, Michael Hansbury, Kevin Bowman et al. · Molecular Cancer Therapeutics · 2010 · 243 citations · Full text

Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials.

Gregory A. Wiseman, Ellen Kornmehl, Bryan R. Leigh et al. · PubMed · 2003 · 216 citations

1–5 of 42